the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..

"we are calling for the immediate implementation of a statutory duty of candour for the health trusts.".: "targeted cgrp small molecule antagonists for acute migraine therapy.".